Research
New technology allows faster, more accurate targeting of radiation against cancer cells.
Researcher Xiaodong Cheng is helping "roadmap" epigenetics, the study of influences on DNA that determine whether genes are turned on or off.
Breast cancer specialist Ruth O'Regan is leading a clinical trial for patients with tumors that are especially resistant to treatment.
Oncologist Ned Waller heads the clinical trials unit at Emory's Winship Cancer Institute.
Infectious disease expert Srilatha Edupuganti works with volunteers in clinical trials of an AIDS vaccine at Emory's Hope Clinic.
The Emory University School of Medicine (SOM) has had a remarkable research trajectory over the past 20 years, during which we have consistently been one of the fastest growing research institutions in terms of total NIH awards awarded to each of the nation’s 131 MD-granting accredited medical schools. In recent years we have lessened our reliance on financial metrics as surrogates of research excellence in favor of recognizing outstanding accomplishments. I invite you to explore our MilliPub Club and Gamechangers, to become familiar with the range of research core facilities and other resources supported by SOM, and to contact me with questions.
- Ray Dingledine, PhD, Executive Associate Dean for Research
Limited Funding Opportunities
Deadline:
02-20-2015
Deadline:
02-24-2015Coordinated by OSP
Core Labs
- Biomedical Imaging Technology Center (BITC)
- Emory Center for Systems Imaging
- Emory Personalized Immunotherapy Center (EPIC)
- Emory Integrated Genomics Core (EIGC)
- Emory Integrated Proteomics Core
- Flow Cytometry
- Integrated Cellular Imaging
- Robert P. Apkarian Integrated Electron Microscopy Core
- Rodent Behavioral Core Facility
- Transgenic Mouse & Gene Targeting Core
- Service Centers
